The Pediatric infectious disease journal
-
Pediatr. Infect. Dis. J. · Jul 2003
Comparative StudyClindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children.
Community-acquired, methicillin-resistant Staphylococcus aureus (CA-MRSA) is an established pathogen in several areas of the United States, but experience with clindamycin for the treatment of invasive MRSA infections is limited. We compared the outcome of therapy for MRSA with that of methicillin-susceptible (MSSA) invasive infections in children treated with clindamycin, vancomycin or beta-lactam antibiotics. ⋯ Clindamycin was effective in treating children with invasive infections caused by susceptible CA-MRSA isolates.